There is no set timeline for how long someone should take Suboxone. The FDA states there is no maximum recommended duration and that patients “may require treatment indefinitely.” For most people with opioid use disorder, the evidence strongly favors staying on Suboxone for at least a year, and many addiction specialists now recommend open-ended maintenance treatment rather than a fixed stop date.
That answer might not be what you were hoping to hear, especially if you’re eager to stop. But the data on what happens when people come off Suboxone too early is striking, and understanding it can help you make a more informed decision with your prescriber.
Why Longer Treatment Produces Better Outcomes
Relapse rates during Suboxone treatment follow a pattern that might seem counterintuitive. In the first three months, between 13% and 41% of patients relapse. By six months, that range climbs to roughly 40% to 52%. But among patients who make it to a full year, relapse rates drop to between 22% and 25%. The longer you stay in treatment, the more your brain chemistry stabilizes, your routines change, and your exposure to triggers decreases. Stopping before that stabilization happens leaves you vulnerable.
The real danger shows up after discontinuation. A CDC-affiliated study found that the risk of suicide or overdose death was more than six times higher in the second week after stopping Suboxone compared to people still receiving treatment. That spike in risk reflects what happens when tolerance drops: your body can no longer handle the same dose of opioids it once could, and a relapse that might not have been fatal six months earlier becomes deadly.
What the Evidence Says About Minimum Duration
Most clinical guidelines converge on at least 12 months as a minimum, but increasingly the recommendation is to continue as long as Suboxone is helping. The VA describes buprenorphine for opioid use disorder as a “lifelong, lifesaving treatment.” This framing puts it in the same category as medications for diabetes or high blood pressure: you take it because it manages a chronic condition, not because you failed to recover.
Shorter courses, sometimes called medically managed withdrawal, have consistently poor long-term results. One large multi-site study compared a 7-day taper to a 28-day taper after stabilization. At the end of the taper itself, 44% of the short-taper group tested opioid-free. But at one month and three months after stopping, both groups had nearly identical results: only 12% to 18% were still opioid-free. The taper speed didn’t matter much. What mattered was that they stopped.
Factors That Affect Your Timeline
Not everyone needs Suboxone for the same length of time, and a few key factors shape the conversation you should have with your prescriber.
- Severity and duration of opioid use: Someone who used prescription opioids for a few months after surgery is in a very different situation than someone with a decade-long history of heroin or fentanyl use. Longer and more severe use histories generally call for longer maintenance.
- Previous relapse attempts: If you’ve tried stopping Suboxone before and relapsed, that’s important clinical information. Each relapse carries real risk, and it may signal that your brain needs more time on medication.
- Stability of your environment: Stable housing, employment, supportive relationships, and distance from active drug use all matter. People with strong recovery infrastructure may be better candidates for an eventual taper, while those in less stable situations benefit from staying on treatment longer.
- Mental health conditions: Depression, anxiety, PTSD, and other conditions significantly increase relapse risk. If these aren’t well managed, discontinuing Suboxone adds another layer of vulnerability.
Suboxone for Pain vs. Addiction
If you’re taking buprenorphine for chronic pain rather than opioid use disorder, the calculus is different. The VA recommends using buprenorphine for pain “at the lowest dose and for the shortest duration necessary.” The goal with pain management is improving function and quality of life, so if non-opioid treatments can achieve that, tapering off is more straightforward and carries less risk of the kind of catastrophic relapse that threatens people with addiction.
For opioid use disorder, the priority shifts toward harm reduction and survival. That’s why the same medication carries such different duration recommendations depending on why you’re taking it.
Long-Term Side Effects to Know About
If you’re weighing indefinite treatment, it’s reasonable to wonder what years on Suboxone might do to your body. The most common side effects that tend to persist include excessive sweating, constipation, decreased sex drive, and sedation. These are generally dose-related, meaning lower doses produce fewer problems.
There are also signals worth monitoring over time. Case reports have linked long-term use to hormonal changes, including low testosterone and reduced bone density, though two studies found no clear correlation between testosterone levels and how long someone had been on the medication or how high their dose was. Sexual dysfunction has been reported at elevated rates, and researchers believe this might involve mechanisms beyond hormone suppression alone. These are manageable concerns, especially compared to the alternative risks of untreated opioid use disorder, but they’re worth discussing with your prescriber so they can check relevant lab work periodically.
What Tapering Actually Looks Like
If you and your prescriber decide the time is right, tapering is a slow, gradual process. There’s no standard schedule that works for everyone, but most clinicians reduce the dose in small increments over weeks to months, pausing or slowing down if withdrawal symptoms become uncomfortable. Rushing the process doesn’t improve outcomes. The research comparing 7-day and 28-day tapers found no advantage to dragging out the taper itself, but both of those timelines are far shorter than what most modern clinicians would recommend for someone on long-term maintenance.
The most important thing during a taper is honest communication. If you’re feeling cravings, increased anxiety, or sleep disruption, those are signs to slow down or hold at your current dose. A taper isn’t a test of willpower. It’s a medical process that should be adjusted based on how your body responds.
Many people who attempt to taper find that a low maintenance dose, sometimes as little as 2 mg per day, keeps them stable with minimal side effects. Staying on a low dose indefinitely is a completely valid choice and one that eliminates the heightened overdose risk that comes with full discontinuation.